NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 237 filers reported holding NOVOCURE LTD in Q1 2024. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,625,484 | +9.6% | 561,908 | 0.0% | 1.12% | +12.6% |
| Q1 2024 | $8,782,622 | +4.7% | 561,908 | 0.0% | 0.99% | +31.0% |
| Q4 2023 | $8,389,286 | -21.3% | 561,908 | -14.9% | 0.76% | -25.1% |
| Q3 2023 | $10,663,441 | -55.6% | 660,275 | +14.2% | 1.01% | -47.9% |
| Q2 2023 | $23,991,897 | +1116.6% | 578,118 | +1663.1% | 1.94% | +1089.0% |
| Q1 2023 | $1,971,991 | – | 32,790 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| StepStone Group LP | 1,365,479 | $29,767,000 | 21.90% |
| Tamarack Advisers, LP | 1,115,000 | $24,307,000 | 11.56% |
| COURAGE CAPITAL MANAGEMENT LLC | 275,000 | $5,995,000 | 4.57% |
| GREAT POINT PARTNERS LLC | 753,481 | $16,426,000,000 | 2.44% |
| HARTLINE INVESTMENT CORP/ | 404,052 | $8,808,000 | 2.42% |
| Pier Capital, LLC | 346,350 | $7,550,000 | 1.29% |
| Rhenman & Partners Asset Management AB | 435,000 | $9,483,000 | 1.17% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,029,910 | $22,452,000 | 0.77% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 922,468 | $20,110,000 | 0.49% |
| Hodges Capital Management Inc. | 285,500 | $6,224,000 | 0.49% |